Cargando…
Association study between clinical response to rizatriptan and some candidate genes
The aim of this study was to test genetic differences in the clinical response to rizatriptan in patients affected by migraine without aura. These genetic differences could be explained by various genes, the HTR1B, encoding the 5-HT(1) receptor subtype, MAOA gene that encodes the monoamino-oxidase,...
Autores principales: | Asuni, Carlo, Cherchi, Allesandra, Congiu, Donatella, Piccardi, Maria P., Del Zompo, Maria, Stochino, Maria E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476140/ https://www.ncbi.nlm.nih.gov/pubmed/17563839 http://dx.doi.org/10.1007/s10194-007-0388-5 |
Ejemplares similares
-
Role of dopaminergic system in migraine
por: Cherchi, Alessandra, et al.
Publicado: (2001) -
Arterial spin-labeled MRI study of migraine attacks treated with rizatriptan
por: Kato, Yuji, et al.
Publicado: (2010) -
Rizatriptan versus rizatriptan plus rofecoxib versus rizatriptan plus tolfenamic acid in the acute treatment of migraine
por: Krymchantowski, Abouch Valenty, et al.
Publicado: (2004) -
Rizatriptan in the treatment of migraine
por: Láinez, Miguel JA
Publicado: (2006) -
Frovatriptan and Rizatriptan Economic EVAluation: the FREEVA study
por: Lisotto, Carlo, et al.
Publicado: (2013)